Survival after combined resection and ablation is not inferior to that after resection alone, in patients with four or more colorectal liver metastases

Purpose Colorectal liver metastases (CRLM) are the predominant factor limiting survival in patients with colorectal cancer. Multimodal treatment strategies are frequently necessary to achieve total tumor elimination. This study examines the efficacy of liver resection combined with local ablative th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Langenbeck's archives of surgery 2023-08, Vol.408 (1), p.343-343, Article 343
Hauptverfasser: Amygdalos, Iakovos, Hitpass, Lea, Schmidt, Felix, Josephs, Gerrit, Bednarsch, Jan, Berres, Marie-Luise, Lüdde, Tom, Olde Damink, Steven W. M., Ulmer, Tom Florian, Neumann, Ulf P., Bruners, Philipp, Lang, Sven Arke
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose Colorectal liver metastases (CRLM) are the predominant factor limiting survival in patients with colorectal cancer. Multimodal treatment strategies are frequently necessary to achieve total tumor elimination. This study examines the efficacy of liver resection combined with local ablative therapy in comparison to liver resection only, in the treatment of patients with ≥ 4 CRLM. Methods This retrospective cohort study was conducted at the University Hospital RWTH Aachen, Germany. Patients with ≥ 4 CRLM in preoperative imaging, who underwent curative resection between 2010–2021, were included. Recurrent resections and deaths in the early postoperative phase were excluded. Ablation modalities included radiofrequency or microwave ablation, and irreversible electroporation. Differences in overall- (OS) and recurrence-free-survival (RFS) between patients undergoing combined resection-ablation vs. resection only, were examined. Results Of 178 included patients, 46 (27%) underwent combined resection-ablation and 132 (73%) resection only. Apart from increased rates of adjuvant chemotherapy in the first group (44% vs. 25%, p  = 0.014), there were no differences in perioperative systemic therapy. Kaplan–Meier and log-rank test analyses showed no statistically significant differences in median OS (36 months for both, p  = 0.638) or RFS (9 months for combined resection-ablation vs. 8 months, p  = 0.921). Cox regression analysis showed a hazard ratio of 0.891 ( p  = 0.642) for OS and 0.981 ( p  = 0.924) for RFS, for patients undergoing resection only. Conclusion For patients with ≥ 4 CRLM, combined resection-ablation is a viable option in terms of OS and RFS. Therefore, combined resection-ablation should be considered for complete tumor clearance, in patients with multifocal disease.
ISSN:1435-2451
1435-2443
1435-2451
DOI:10.1007/s00423-023-03082-1